FDA Inspection 1111694 — Ari-Med Pharmaceuticals
The FDA completed an inspection of Ari-Med Pharmaceuticals on October 24, 2019 in Tempe, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 24, 2019
- Fiscal Year
- 2020
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Tempe, AZ (United States)